Id |
Subject |
Object |
Predicate |
Lexical cue |
SS1_23511244_0_0 |
0-59 |
expanded |
denotes |
Pioglitazone Randomised Italian Study on Metabolic Syndrome |
SS2_23511244_0_0 |
61-67 |
abbr |
denotes |
PRISMA |
SS1_23511244_2_0 |
253-277 |
expanded |
denotes |
Type 2 diabetes mellitus |
SS2_23511244_2_0 |
279-283 |
abbr |
denotes |
T2DM |
SS1_23511244_4_0 |
422-437 |
expanded |
denotes |
HDL cholesterol |
SS2_23511244_4_0 |
439-444 |
abbr |
denotes |
HDL-C |
SS1_23511244_5_0 |
512-530 |
expanded |
denotes |
metabolic syndrome |
SS2_23511244_5_0 |
532-534 |
abbr |
denotes |
MS |
SS1_23511244_7_0 |
691-705 |
expanded |
denotes |
hemoglobin A1c |
SS2_23511244_7_0 |
707-712 |
abbr |
denotes |
HbA1c |
SS1_23511244_12_0 |
1384-1431 |
expanded |
denotes |
homeostasis model assessment-insulin resistance |
SS2_23511244_12_0 |
1433-1440 |
abbr |
denotes |
HOMA-IR |
SS1_23511244_14_0 |
1865-1886 |
expanded |
denotes |
myocardial infarction |
SS2_23511244_14_0 |
1888-1890 |
abbr |
denotes |
MI |
AE1_23511244_0_0 |
SS1_23511244_0_0 |
SS2_23511244_0_0 |
abbreviatedTo |
Pioglitazone Randomised Italian Study on Metabolic Syndrome,PRISMA |
AE1_23511244_12_0 |
SS1_23511244_12_0 |
SS2_23511244_12_0 |
abbreviatedTo |
homeostasis model assessment-insulin resistance,HOMA-IR |
AE1_23511244_14_0 |
SS1_23511244_14_0 |
SS2_23511244_14_0 |
abbreviatedTo |
myocardial infarction,MI |
AE1_23511244_2_0 |
SS1_23511244_2_0 |
SS2_23511244_2_0 |
abbreviatedTo |
Type 2 diabetes mellitus,T2DM |
AE1_23511244_4_0 |
SS1_23511244_4_0 |
SS2_23511244_4_0 |
abbreviatedTo |
HDL cholesterol,HDL-C |
AE1_23511244_5_0 |
SS1_23511244_5_0 |
SS2_23511244_5_0 |
abbreviatedTo |
metabolic syndrome,MS |
AE1_23511244_7_0 |
SS1_23511244_7_0 |
SS2_23511244_7_0 |
abbreviatedTo |
hemoglobin A1c,HbA1c |